The effect of dietary nitrite and nitrate on the metabolism of sulphadimidine administered orally to pigs

Stability of sulphadimidine during raw fermented sausage preparation

The transformation of sulphadimidine (SDM) during raw fermented sausage preparation was studied to elucidate the SDM decrease found in an earlier study. The raw fermented sausages were prepared from batters containing 1 and 10 mg [14C]-SCM kg-1. The sausages and the brines were analysed using methods based on solid-phase extraction followed by HPLC combined with liquid scintillation counting. It can be concluded that the decrease in SDM level is mainly caused by (i) leaching into the brine (approx. 25%), (ii) transformation of SDM, possibly by reactions with components in the sausage or the brine, as the presence of five reaction products from SDM could be demonstrated, and (iii) formation of bound residues (approx. 20%).

High-performance liquid chromatographic method for the routine determination of sulphadimidine, its hydroxy metabolites and N4-acetylsulphadimidine in body fluids and cell culture media

A simple high-performance liquid chromatographic method is presented for the determination of trace amounts of sulphadimidine (SDD), its hydroxylated metabolites and N4-acetyl-SDD in blood plasma, urine, hepatocyte culture media and microsomal incubations. The synthesis of 5-hydroxy-SDD and an improved method for the isolation of 4-methylhydroxy-SDD from urine are described and their respective specific absorption coefficients at 265 nm are calculated by on-line radiochemical and ultraviolet detection. The limit of detection of the analytical method is 0.05 micrograms/ml for SDD and its hydroxy metabolites and 0.2 micrograms/ml for N4-acetyl-SDD. Linear calibration graphs for SDD and its metabolites were constructed from 0.2 to 50 micrograms/ml. The method has been applied to biotransformation studies in vivo and in vitro.

Metabolism of 1,3-di-(4-[N-(4,6-dimethyl-2-pyrimidinyl)sulphamoyl] phenyl)triazene (DDPSPT) in the rat

1. Six hours after rats were orally dosed with 1,3-di-(4-[N-(4,6-dimethyl-2-pyrimidinyl)sulphamoyl][U-14C]phenyl) triazene (14C-DDPSPT), approx. 81% of the 14C remained in the gastrointestinal tract (gut) and less than 3% was excreted in the urine. 2. Six hours after dosing, more than half of the 14C in the gut was present as DDPSPT. 14C-Labelled metabolites in the gut included 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)-benzenesulphonamide (Sulmet), N4-glucosyl-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulphonamide (N4-gluc-Sulmet), 4-acetamido-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulphonamide (N4-acetyl-Sulmet), and [N-4,6-dimethyl-2-pyrimidinyl) benzenesulphonamide] (desamino-Sulmet). 3. 14C-Labelled compounds in the blood, liver and skeletal muscle included DDPSPT, Sulmet, N4-gluc-Sulmet, N4-acetyl-Sulmet and desamino-Sulmet. 4. There was little or no reaction of DDPSPT with cysteine, bovine serum albumin, AMP, GMP, or calf thymus deoxyribonucleic acid in vitro (pH 3, 5, 7 or 8).

The use of porcine hepatocytes for biotransformation studies of veterinary drugs

1. Cultures of porcine hepatocytes with high viability were isolated from a liver sample by a simple procedure. In ageing monolayer cultures the cytochrome P-450 content and 7-ethoxycoumarin-O-deethylase activity decreased gradually while glutathione levels increased. 2. The nitrofuran, furazolidone, was rapidly metabolized, partly resulting in the formation of 3-(4-cyano-2-oxobutylidene amino)-2-oxazolidone. 3. Acetylating and deacetylating activities towards sulphadimidine and its N4-acetyl metabolite were present in porcine hepatocytes. Relative and absolute levels of these activities varied in different batches of hepatocytes. 4. No differences were seen in a number of enzyme activities measured in cytosolic and microsomal fractions isolated from different lobes of one liver. Differences between livers from different animals were marked.